Search

Editors

Richard L. Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Elizabeth K. Spahn Editor Emeritus

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor


FCPA Blog Daily News

Entries in China (793)

Thursday
Feb082018

Feds open new GSK China bribery investigation

GlaxoSmithKline said in a securities filing Wednesday that the DOJ and SEC asked for information about third-party advisers the company hired in China during a corruption investigation there.

Click to read more ...

Friday
Jan262018

China company convicted of stealing U.S. wind turbine technology

China's biggest wind turbine maker was convicted Wednesday by a federal jury of nearly destroying an American company by stealing its trade secrets.

Click to read more ...

Thursday
Jan182018

Dale Ko: Shenzhen awards first ISO 37001 certificate

In November the Shenzhen Institute of Standards and Technology awarded the first ISO 37001 Anti-Bribery Management System certificate in China, an important milestone in the country's persistent fight against corruption.

Click to read more ...

Friday
Jan122018

Does the U.S. play politics with the FCPA?

The arrest of Hong Kong's former home secretary, Patrick Ho, for allegedly bribing Africa officials on behalf of a Chinese energy company, has triggered accusations that America uses FCPA enforcement to promote a political agenda.

Click to read more ...

Tuesday
Jan092018

Former Hong Kong official pleads not guilty, denied bail

The former Hong Kong home secretary indicted for allegedly bribing Africa officials on behalf of a Chinese energy company pleaded not guilty Monday.

Click to read more ...

Thursday
Nov302017

Companies create special FCPA disclosures for China risks

It has been a common practice for SEC-registered companies with international operations to include FCPA enforcement as a "risk factor" that investors should consider before buying the company's securities.

Click to read more ...

Wednesday
Nov292017

Manseau and Zeng: More enforcement risk for China joint ventures

Having recently toughened up its anti-bribery laws, China is now aiming to expand its oversight of corruption in the public sector, possibly leading to increased enforcement efforts against both domestic and foreign companies.

Click to read more ...

Tuesday
Nov282017

Andy Spalding: Corruption isn't someone else's problem

The FCPA is both a confession, and a conviction. We confess that corruption is not somebody else’s problem; it’s our problem. We do not point a finger; we look in the mirror.

Click to read more ...

Monday
Nov202017

DOJ charges two in Chinese plot to bribe Africa officials

The DOJ unsealed a criminal complaint Monday charging the head of a Hong Kong-based NGO and the former foreign minister of Senegal with bribing high-level officials in Chad and Uganda to help a Chinese oil and gas company.

Click to read more ...

Monday
Nov062017

Eric Carlson: Measuring President Xi’s ‘crushing tide’ against graft

Almost exactly five years ago, I wrote a post for the FCPA Blog analyzing the impact that China’s leadership transition to Xi Jinping would have on anti-corruption enforcement in China. This post assesses those predictions and makes new ones for the coming five years, in light of the recently concluded Party Congress.

Click to read more ...

Thursday
Oct192017

Jerry Fang: China arms corruption fighters with a sharp sword

With the world media attention focused on the 19th National Congress of Chinese Communist Party (CPC), it is worthwhile to pay attention to the nation-wide roll-out of the new anti-corruption regime of the National Supervision Commission (NSC) and introduction of the national supervision law, as just announced by President Xi during his  opening speech.

Click to read more ...

Wednesday
Sep132017

Life Science Alert: China judicial interpretation criminalizes submission of false clinical trial information

A recent judicial interpretation issued by China’s top judicial and prosecutorial bodies now criminalizes submitting falsified nonclinical study or clinical study reports and related materials. This could affect life sciences companies and contract research organizations operating in China.

Click to read more ...